Literature DB >> 7004964

Blood glucose control and insulin clearance in unrestrained diabetic dogs portally infused with a portable insulin delivery system.

Y Goriya, A Bahoric, E B Marliss, B Zinman, A M Albisser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004964     DOI: 10.1007/bf00281825

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  34 in total

1.  Effect in dogs of various portal vein shunts on response to insulin.

Authors:  T E STARZL; G W BUTZ; W H MEYER; E E TOROK; R E DOLKART
Journal:  Am J Physiol       Date:  1962-08

2.  A comparison of the effect of the intraportal and intravenous administration of I131-insulin on peripheral blood glucose and serum radioactivity.

Authors:  F I MARTIN; J R LEONARDS; M MILLER
Journal:  Metabolism       Date:  1959-07-02       Impact factor: 8.694

3.  The physiologic significance of portal vs. peripheral injection of insulin in man.

Authors:  S Baruh
Journal:  Am J Med Sci       Date:  1975 Jan-Feb       Impact factor: 2.378

4.  The metabolic response to glycemic control by the artificial pancreas in diabetic man.

Authors:  B Zinman; E F Stokes; A M Albisser; A K Hanna; H L Minuk; A N Stein; B S Leibel; E B Marliss
Journal:  Metabolism       Date:  1979-05       Impact factor: 8.694

5.  The microcirculatory hepatic unit.

Authors:  A M Rappaport
Journal:  Microvasc Res       Date:  1973-09       Impact factor: 3.514

6.  For insulin infusion: a miniature precision peristaltic pump and silicone rubber reservoir.

Authors:  W S Jackman; W Lougheed; E B Marliss; B Zinman; A M Albisser
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

7.  Normalization of plasma glucose of unstable diabetes: studies under ambulatory, fed conditions with pumped intravenous insulin.

Authors:  F J Service
Journal:  J Lab Clin Med       Date:  1978-03

8.  Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus.

Authors:  K Irsigler; H Kritz
Journal:  Diabetes       Date:  1979-03       Impact factor: 9.461

9.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28

10.  Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.

Authors:  A K Hanna; B Zinman; A F Nakhooda; H L Minuk; E F Stokes; A M Albisser; B S Leibel; E B Marliss
Journal:  Metabolism       Date:  1980-04       Impact factor: 8.694

View more
  6 in total

Review 1.  Pharmacokinetic considerations of new insulin formulations and routes of administration.

Authors:  A Hoffman; E Ziv
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 2.  Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.

Authors:  W Blair Geho; Hans C Geho; John R Lau; Theophilus J Gana
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

3.  Differential binding of sulphated insulin to adipocytes and hepatocytes.

Authors:  S Zeuzem; R Taylor; L Agius; A M Albisser; K G Alberti
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

4.  Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.

Authors:  T Ishida; Z Chap; J Chou; R Lewis; C Hartley; M Entman; J B Field
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin.

Authors:  J Jaspan; K Polonsky
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

6.  The metabolic and hormonal responses to a mixed meal in unrestrained pancreatectomised dogs chronically treated by portal or peripheral insulin infusion.

Authors:  Y Goriya; A Bahoric; E B Marliss; B Zinman; A M Albisser
Journal:  Diabetologia       Date:  1981-07       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.